Not Yet Recruiting
A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer
NCT07466901
- Conditions
- Adjuvant Therapy, Cervical Cancer, Female Urogenital Diseases, +13 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China